NSE - Free Realtime Quote INR

Bliss GVS Pharma Limited (BLISSGVS.NS)

138.16
+2.32
+(1.71%)
As of 10:02:33 AM GMT+5:30. Market Open.
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
8,097,262
8,097,262
7,702,449
7,474,287
7,379,285
Cost of Revenue
4,136,882
4,136,882
3,821,157
4,013,249
3,909,820
Gross Profit
3,960,380
3,960,380
3,881,292
3,461,038
3,469,465
Operating Expense
2,987,723
2,987,723
2,638,864
2,453,706
2,288,020
Operating Income
972,657
972,657
1,242,428
1,007,332
1,181,445
Net Non Operating Interest Income Expense
-81,200
-81,200
-69,121
37,592
48,390
Pretax Income
1,256,392
1,256,392
1,168,720
1,060,716
541,653
Tax Provision
353,839
353,839
352,941
293,368
310,388
Net Income Common Stockholders
842,993
842,993
754,541
708,588
150,402
Diluted NI Available to Com Stockholders
842,993
842,993
754,541
708,588
150,402
Basic EPS
5.67
8.02
7.23
6.83
1.46
Diluted EPS
5.63
7.95
7.11
6.72
1.43
Basic Average Shares
104,808.88
105,111.35
104,362.52
103,805.63
103,335.82
Diluted Average Shares
105,919.94
106,036.86
106,123.91
105,478.88
105,201.07
Rent Expense Supplemental
--
--
16,499
19,021
15,632
Total Expenses
7,124,605
7,124,605
6,460,021
6,466,955
6,197,840
Net Income from Continuing & Discontinued Operation
842,993
842,993
754,541
708,588
150,402
Normalized Income
842,993
842,993
958,332.89
721,022.94
783,986.70
Interest Income
--
--
117,904
75,041
88,181
Interest Expense
81,200
81,200
69,121
32,444
29,295
Net Interest Income
-81,200
-81,200
-69,121
37,592
48,390
EBIT
1,337,592
1,337,592
1,237,841
1,093,160
570,948
EBITDA
1,631,768
1,631,768
1,501,639
1,279,893
744,256
Reconciled Cost of Revenue
4,136,882
4,136,882
3,821,157
4,013,249
3,909,820
Reconciled Depreciation
294,176
294,176
263,798
186,733
173,308
Net Income from Continuing Operation Net Minority Interest
842,993
842,993
754,541
708,588
150,402
Total Unusual Items Excluding Goodwill
0
0
-291,961
-17,189
-905,121
Total Unusual Items
0
0
-291,961
-17,189
-905,121
Normalized EBITDA
1,631,768
1,631,768
1,793,600
1,297,082
1,649,377
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-88,169.11
-4,754.06
-271,536.30
3/31/2022 - 7/26/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BALPHARMA.BO Bal Pharma Limited
102.25
+1.28%
 
MANGALAM.NS Mangalam Drugs & Organics Limited
82.18
+0.37%
 
LASA.NS Lasa Supergenerics Limited
13.33
-0.74%
 
INDSWFTLTD.NS Ind-Swift Limited
17.69
+1.62%
 
NECLIFE.BO Nectar Lifesciences Limited
23.65
+0.51%
 
ZENOTECH.BO Zenotech Laboratories Limited
63.97
+1.75%
 
INDSWFTLAB.NS Ind-Swift Laboratories Limited
94.31
+0.02%
 
APLLTD.NS Alembic Pharmaceuticals Limited
991.40
+0.16%
 
SYNCOMF.NS Syncom Formulations (India) Limited
21.91
+2.24%
 
INDOCO.NS Indoco Remedies Limited
285.95
-2.02%